Pardes to go public, says Covid-19 antiviral pill does not need booster
Pardes Biosciences on Tuesday said early human testing shows that its experimental COVID 19 antiviral pill works as a standalone treatment and announc...
Stay updated with breaking news from Fs Development Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pardes Biosciences on Tuesday said early human testing shows that its experimental COVID 19 antiviral pill works as a standalone treatment and announc...
Pardes Biosciences on Tuesday said early human testing shows that its experimental COVID-19 antiviral pill works as a standalone treatment and announced plans…
The SPAC market is weakening alongside the broader market as IPOs are struggling to hold NAV, deSPACs are dropping, warrants are dropping and the press is back with a negative narrative.
Richard Branson's second SPAC is taking Grove Collaborative public. dMY has another feather in its cap as DMYQ changed to PL and surged its first day on the NYSE. Oh, and DWAC surged again, up 28%.
No primary market activity for SPACs, which remain below NAV on average. Ackman returns with Friday SPARC filing for Pershing Square.